Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, Frédérique, Cannon, Catherine, Barbour, Robin, Burke, Rae-Lyn, Games, Dora, Grajeda, Henry, Guido, Teresa, Hu, Kang +15 more·2000·Nature Medicine

Cited by (1,003)

Items 301–400 of 1,003

  1. Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists
    David Allan Butterfield, Sue T. Griffin, Gerald W Münch, Giulio Maria Pasinetti · 2002 · Journal of Alzheimer s Disease
  2. Young microglia restore amyloid plaque clearance of aged microglia
    Daria, Anna, Colombo, Alessio, Llovera, Gemma, Hampel, Heike, Willem, Michael, Liesz, Arthur, Haass, Christian, Tahirovic, Sabina · 2017 · The EMBO Journal
  3. Current approaches in the treatment of Alzheimer's disease
    Reena S. Shah, Hyoung‐gon Lee, Xiongwei Zhu, George L. Perry, Mark A. Smith, Rudy J. Castellani · 2008 · Biomedicine & Pharmacotherapy
  4. Biopharmaceutical drug targeting to the brain
    William M. Pardridge · 2010 · Journal of drug targeting
  5. Rapid cell death is preceded by amyloid plaque-mediated oxidative stress
    Xie, Hong, Hou, Steven, Jiang, Jun, Sekutowicz, Maria, Kelly, Jonathan, Bacskai, Brian J. · 2013 · Proceedings of the National Academy of Sciences
  6. Immunotherapy for Alzheimer’s disease: hoops and hurdles
    Lemere, Cynthia A · 2013 · Molecular Neurodegeneration
  7. Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
    John Howard Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Darell D. Bigner · 2008 · Seminars in Immunology
  8. α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
    Yanamandra, Kiran, Gruden, Marina A., Casaite, Vida, Meskys, Rolandas, Forsgren, Lars, Morozova-Roche, Ludmilla A. · 2011 · PLoS ONE
  9. Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
    Sriram Venneti, Clayton A. Wiley, Julia Kofler · 2008 · Journal of Neuroimmune Pharmacology
  10. Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease
    Luigi Cesare Bergamaschini, Emanuela Rossi, Claudio Storini, Simone Pizzimenti, Maria Distaso, Carlo Perego, Ada De Luigi, Carlo Vergani, Maria Grazia De Simoni · 2004 · Journal of Neuroscience
  11. Nuclear Receptors License Phagocytosis by Trem2<sup>+</sup>Myeloid Cells in Mouse Models of Alzheimer's Disease
    Savage, Julie C., Jay, Taylor, Goduni, Elanda, Quigley, Caitlin, Mariani, Monica M., Malm, Tarja, Ransohoff, Richard M., Lamb, Bruce T., Landreth, Gary E. · 2015 · The Journal of Neuroscience
  12. Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
    Jiaping Gu, Erin E. Congdon, Einar M. Sigurdsson · 2013 · Journal of Biological Chemistry
  13. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
    Erika Chung, Yong Ji, Yanjie Sun, Richard J. Kascsak, Regina B. Kascsak, Pankaj D Mehta, Stephen M. Strittmatter, Thomas Wısnıewskı · 2010 · BMC Neuroscience
  14. Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance
    Thierry Bussière, Frédérique Bard, Robin Barbour, Henry Grajeda, Terry Guido, Karen Khan, Dale Schenk, Dora Games, Peter A. Seubert, Manuel Buttini · 2004 · American Journal Of Pathology
  15. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
    Jeroen J.M. Hoozemans, Robert Veerhuis, Annemieke J.M. Rozemüller, Piet Eikelenboom · 2005 · International Journal of Developmental Neuroscience
  16. A High-Throughput Screen for Compounds That Inhibit Aggregation of the Alzheimer’s Peptide
    Woojin Kim, Yun‐Kyoung Kim, Jaeki Min, Dong Jin Kim, Young‐Tae Chang, Michael H. Hecht · 2006 · ACS Chemical Biology
  17. The role of beta amyloid in Alzheimer?s disease: still a cause of everything or the only one who got caught?
    Giuseppe Verdile · 2004 · Pharmacological Research
  18. Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
    Martin C. Herzig, William E. Van Nostrand, Mathias Jucker · 2006 · Brain Pathology
  19. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease
    Dan Frenkel, Ruth Maron, David S. Burt, Howard L. Weiner · 2005 · Journal of Clinical Investigation
  20. Hypothalamic innate immune reaction in obesity
    Kälin, Stefanie, Heppner, Frank L., Bechmann, Ingo, Prinz, Marco, Tschöp, Matthias H., Yi, Chun-Xia · 2015 · Nature Reviews Endocrinology
  21. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures
    Lih‐Fen Lue · 2001 · Neurobiology of Aging
  22. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice
    Juan Sanchez‐Ramos, Shijie Song, V. M. Sava, Briony J. Catlow, X. Lin, Takashi Mori, Chuanhai Cao, Gary W. Arendash · 2009 · Neuroscience
  23. Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
    Thomas A. Bayer, Oliver Wirths · 2014 · Acta Neuropathologica
  24. Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/-Knock-Out Mice
    Pritam Das, VICTOR G. HOWARD, Nicole Loosbrock, Dennis W. Dickson, Michael Paul Murphy, Todd Eliot Golde · 2003 · Journal of Neuroscience
  25. Alzheimer's disease: treatments in discovery and development
    Martin Citron · 2002 · Nature Neuroscience
  26. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease
    Fujita, Kyota, Motoki, Kazumi, Tagawa, Kazuhiko, Chen, Xigui, Hama, Hiroshi, Nakajima, Kazuyuki, Homma, Hidenori, Tamura, Takuya, Watanabe, Hirohisa, Katsuno, Masahisa et al. · 2016 · Scientific Reports
  27. Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
    Lisbell D. Estrada, Claudio A. Soto · 2006 · Current Topics in Medicinal Chemistry
  28. Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and Where
    Aaron Y. Lai, JoAnne McLaurin · 2012 · Future Neurology
  29. Transplanted astrocytes internalize deposited β‐amyloid peptides in a transgenic mouse model of Alzheimer's disease
    Rea Pihlaja, Jari Koıstınaho, Tarja Malm, Herkko Sikkilä, Seppo Juhani Vainio, Milla Koistinaho · 2007 · Glia
  30. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
    John Tiernan O'Brien, Alistair S. Burns · 2010 · Journal of Psychopharmacology
  31. Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease
    Richard C. Dodel, Harald Juergen Hampel, Candan Depboylu, Suizhen Lin, Feng Gao, Sabine Schock, Steffi Jäckel, Xing Wei, Katharina Büerger, Christine Höft et al. · 2002 · Annals of Neurology
  32. Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease
    Alon Monsonego, Ruth Maron, Victor E. Zota, Dennis J. Selkoe, Howard L. Weiner · 2001 · Proceedings of the National Academy of Sciences
  33. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
    Kim, Jungsu, Eltorai, Adam E.M., Jiang, Hong, Liao, Fan, Verghese, Philip B., Kim, Jaekwang, Stewart, Floy R., Basak, Jacob M., Holtzman, David M. · 2012 · Journal of Experimental Medicine
  34. Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
    Serrano-Pozo, Alberto, William, Christopher M., Ferrer, Isidro, Uro-Coste, Emmanuelle, Delisle, Marie-Bernadette, Maurage, Claude-Alain, Hock, Christoph, Nitsch, Roger M., Masliah, Eliezer, Growdon, John H. et al. · 2010 · Brain
  35. Biological markers of amyloid β-related mechanisms in Alzheimer's disease
    Harald Juergen Hampel, Yong Shen, Dominic M. Walsh, Paul S. S. Aisen, Les M. Shaw, Henrik Zetterberg, John Q. Trojanowski, Kaj Blennow · 2009 · Experimental Neurology
  36. Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids
    Bilal Çakır, Yoshiaki Tanaka, Ferdi Rıdvan Kiral, Yangfei Xiang, Onur Dağliyan, Juan Wang, Maria Lee, Allison Marie Greaney, Woo Sub Yang, Catherine duBoulay et al. · 2022 · Nature Communications
  37. An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
    Anna Lord, Astrid Gumucio, Hillevi Englund, Dag Sehlin, Valentina Screpanti Sundquist, Linda Söderberg, Christer Möller, Pär Gellerfors, Lars Lannfelt, Frida Ekholm Pettersson et al. · 2009 · Neurobiology of Disease
  38. Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease
    Alon Monsonego, Jaime Imitola, Sanja Petrovic, Victor E. Zota, Anna Nemirovsky, Rona Baron, Yair Fisher, Trevor Owens, Howard L. Weiner · 2006 · Proceedings of the National Academy of Sciences
  39. Immunotherapy for Alzheimer's disease
    David S. Gélinas, Kevin Da Silva, Daniela Fenili, Peter St George‐Hyslop, JoAnne McLaurin · 2004 · Proceedings of the National Academy of Sciences
  40. Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
    Lars Lannfelt, Norman R. Relkin, Eric Siemers · 2014 · Journal of Internal Medicine
  41. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia
    Jintao Bao, Liangjun Zheng, Qi Zhang, Xinya Li, Xuefei Zhang, Zeyang Li, Xue Bai, Zhong Zhang, Wei Huo, Xuyang Zhao et al. · 2016 · Protein & Cell
  42. Dominant-negative inhibition of prion replication in transgenic mice
    Véronique Perrier, Kiyotoshi Kaneko, Jiri Safar, Julie A. Vergara, Patrick Tremblay, Stephen J. DeArmond, Fred E. Cohen, Stanley B. Prusiner, Andrew C. Wallace · 2002 · Proceedings of the National Academy of Sciences
  43. Amyloid-β immunisation for Alzheimer's disease
    Wisniewski, Thomas, Konietzko, Uwe · 2008 · The Lancet Neurology
  44. Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
    Steven Samuel Plotkin, Neil R. Cashman · 2020 · Neurobiology of Disease
  45. New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
    Fuller, James P., Stavenhagen, Jeffrey B., Teeling, Jessica L. · 2014 · Frontiers in Neuroscience
  46. Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
    Golnaz Yadollahikhales, Julio C. Rojas · 2023 · Neurotherapeutics
  47. Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
    Eshraghi, Mehdi, Adlimoghaddam, Aida, Mahmoodzadeh, Amir, Sharifzad, Farzaneh, Yasavoli-Sharahi, Hamed, Lorzadeh, Shahrokh, Albensi, Benedict C., Ghavami, Saeid · 2021 · International Journal of Molecular Sciences
  48. Association of Highly Compact Type II Diabetes Related Islet Amyloid Polypeptide Intermediate Species at Physiological Temperature Revealed by Diffusion NMR Spectroscopy
    Ronald Soong, Jeffrey Brender, Peter M. Macdonald, Ayyalusamy Ramamoorthy · 2009 · Journal of the American Chemical Society
  49. Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice
    Donna M. Wilcock, Jennifer Alamed, Paul E. Gottschall, Jan Grimm, Arnon Rosenthal, Jaume Pons, Victoria Ronan, Keisha Symmonds, Marcia N. Gordon, David Morgan · 2006 · Journal of Neuroscience
  50. Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
    Stephen R. Robinson, Glenda M. Bishop · 2002 · Neurobiology of Aging
  51. Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles
    Fan Huang, Jianzu Wang, Aoting Qu, Liangliang Shen, Jinjian Liu, Jianfeng Liu, Zhenkun Zhang, Yingli An, Linqi Shi · 2014 · Angewandte Chemie International Edition
  52. Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
    Mithilesh Kumar Jha, Jong-Heon Kim, Gyun Jee Song, Won‐Ha Lee, In Kyu Lee, Ho‐Won Lee, Seong Soo A. An, SangYun Kim, Kyoungho Suk · 2017 · Progress in Neurobiology
  53. Intranasal Delivery of Bone Marrow-Derived Mesenchymal Stem Cells, Macrophages, and Microglia to the Brain in Mouse Models of Alzheimer's and Parkinson's Disease
    Lusine Danielyan, Sandra Beer‐Hammer, Alexandra Stolzing, Richard Schäfer, Georg Siegel, Claire Fabian, Philipp J. Kahle, Tilo Biedermann, Ali Lourhmati, Marine Buadze et al. · 2014 · Cell Transplantation
  54. Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
    Philine Schneider, Harald Juergen Hampel, Katharina Büerger · 2009 · CNS Neuroscience & Therapeutics
  55. Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation
    Milla Koistinaho, Jari Koıstınaho · 2005 · Brain Research Reviews
  56. Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition
    Pritam Das, Michael Paul Murphy, Linda H. Younkin, Steven G. Younkin, Todd Eliot Golde · 2001 · Neurobiology of Aging
  57. Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound
    Charissa Poon, Dallan McMahon, Kullervo Hynynen · 2016 · Neuropharmacology
  58. Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-Aβ Antibody Administration in PDAPP Mice
    Koenigsknecht-Talboo, Jessica, Meyer-Luehmann, Melanie, Parsadanian, Maia, Garcia-Alloza, Monica, Finn, Mary Beth, Hyman, Bradley T., Bacskai, Brian J., Holtzman, David M. · 2008 · The Journal of Neuroscience
  59. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
    Marc Aurel Busche, Christine Grienberger, Aylin D. Keskin, Beomjong Song, Ulf Neumann, Matthias Staufenbiel, Hans Förstl, Arthur Konnerth · 2015 · Nature Neuroscience
  60. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
    Sebastian Monasor, Laura, Müller, Stephan A, Colombo, Alessio Vittorio, Tanrioever, Gaye, König, Jasmin, Roth, Stefan, Liesz, Arthur, Berghofer, Anna, Piechotta, Anke, Prestel, Matthias et al. · 2020 · eLife
  61. An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β Derivatives
    Einar M. Sigurdsson, Elin Knudsen, Ayodeji A. Asuni, Cheryl J. Fitzer‐Attas, Daniel Sage, David Quartermain, Fernando Goñi, Blas Frangione, Thomas Wısnıewskı · 2004 · Journal of Neuroscience
  62. Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens
    Charles L. Murphy, Manfred Eulitz, Rudi Hrncic, Knut Sletten, Per Westermark, Teresa K. Williams, Sallie D. Macy, Craig Wooliver, Jonathan S. Wall, Deborah T. Weiss et al. · 2001 · American Journal of Clinical Pathology
  63. Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
    Pardridge, William M. · 2017 · BioDrugs
  64. Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
    Martin Rhys Farlow, Niels Andreasen, Marie‐Emmanuelle Riviere, Igor Voštiar, Alessandra Vitaliti, Judit Sóvágó, Angelika Caputo, Bengt G. Winblad, Ana Graf · 2015 · Alzheimer s Research & Therapy
  65. Neuroinflammatory responses in Alzheimer’s disease
    Cira Dansokho, Michael Thomas Heneka · 2017 · Journal of Neural Transmission
  66. IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
    Shimizu, Eisuke, Kawahara, Kohichi, Kajizono, Makoto, Sawada, Makoto, Nakayama, Hitoshi · 2008 · The Journal of Immunology
  67. Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
    Dá Mesquita, Sandro, Ferreira, Ana Catarina, Sousa, João Carlos, Correia-Neves, Margarida, Sousa, Nuno, Marques, Fernanda · 2016 · Neuroscience &amp; Biobehavioral Reviews
  68. Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
    Mikko Hölttä, Oskar Hansson, Ulf Andréasson, Joakim Hertze, Lennart Minthon, Katarina Nägga, Niels Andreasen, Henrik Zetterberg, Kaj Blennow · 2013 · PLoS ONE
  69. Antibody therapies in CNS diseases
    Per‐Ola Freskgård, Eduard Urich · 2016 · Neuropharmacology
  70. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem cells and stromal ependymal cells
    Mathieu Hauwel, Emeline Furon, Cécile Canova, Mark Griffiths, Jim W. Neal, Philippe Gasque · 2005 · Brain Research Reviews
  71. Autoantibodies to amyloid-? and Alzheimer's disease
    Bradley T. Hyman, Carolyn Reams Smith, Ilya Buldyrev, Christa M. Whelan, Harold Brown, Ming‐Xin Tang, Richard P Mayeux · 2001 · Annals of Neurology
  72. The transcription factor PU.1 is critical for viability and function of human brain microglia
    Smith, Amy M., Gibbons, Hannah M., Oldfield, Robyn L., Bergin, Peter M., Mee, Edward W., Faull, Richard L. M., Dragunow, Mike · 2013 · Glia
  73. Involvement of Fc Receptors in Disorders of the Central Nervous System
    Eitan Okun, Mark P. Mattson, Thiruma Valavan Arumugam · 2009 · NeuroMolecular Medicine
  74. Oral vaccination with a viral vector containing Aβ cDNA attenuates age‐related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
    Akihiro Mouri, Yukihiro Noda, Hideo Hara, Hiroyuki Mizoguchi, Takeshi Tabira, Toshitaka Nabeshima · 2007 · The FASEB Journal
  75. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
    Haass, Christian, Selkoe, Dennis · 2022 · PLOS Biology
  76. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease
    Zhao, Peng, Xu, Yuanzhong, Jiang, LuLin, Fan, Xuejun, Li, Leike, Li, Xin, Arase, Hisashi, Zhao, Yingjun, Cao, Wei, Zheng, Hui et al. · 2022 · Science Translational Medicine
  77. Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice
    Cynthia Ann Lemere · 2003 · Neurobiology of Disease
  78. Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
    2008 · Handbook of Clinical Neurology
  79. PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
    Venneti, Sriram, Lopresti, Brian J., Wang, Guoji, Hamilton, Ronald L., Mathis, Chester A., Klunk, William E., Apte, Udayan M., Wiley, Clayton A. · 2009 · Neurobiology of Aging
  80. Alzheimer disease therapy: Can the amyloid cascade be halted?
    Golde, Todd E. · 2003 · Journal of Clinical Investigation
  81. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease
    Hana N. Dawson, Viviana Cantillana, Marilyn Jansen, H. Wang, Michael Peter Vitek, Donna M. Wilcock, John Lynch, Daniel T. Laskowitz · 2010 · Neuroscience
  82. EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma
    Bryan D. Choi, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Roger E. McLendon, Darell D. Bigner, John Howard Sampson · 2009 · Brain Pathology
  83. Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
    Tengfei Li, Matthias Vandesquille, Fani Koukouli, Clémence Dudeffant, Ihsen Youssef, Pascal Lenormand, Christelle Ganneau, Uwe Maskos, Christian Czech, Fiona Grueninger et al. · 2016 · Journal of Controlled Release
  84. Human anti- -amyloid antibodies block -amyloid fibril formation and prevent -amyloid-induced neurotoxicity
    Yansheng Du · 2003 · Brain
  85. Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
    Boche, Delphine, Denham, Nathan, Holmes, Clive, Nicoll, James A. R. · 2010 · Acta Neuropathologica
  86. Cannabidiol enhances microglial phagocytosis via transient receptor potential ( TRP ) channel activation
    Samia Hassan, Khalil Eldeeb, Paul J. Millns, Andrew J. Bennett, S P H Alexander, David A. Kendall · 2014 · British Journal of Pharmacology
  87. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
    Philippe Patrick Monnier, Robin J. Vigouroux, Nardos G. Tassew · 2013 · Antibodies
  88. 1α,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-β Phagocytosis and Inflammation in Alzheimer's Disease Patients
    Mathew T. Mizwicki, Guanghao Liu, Milan Fiala, Larry I. Magpantay, James William Sayre, Avi Siani, Michelle Mahanian, Rachel E. Weitzman, Eric Y. Hayden, Mark J. Rosenthal et al. · 2013 · Journal of Alzheimer s Disease
  89. Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
    Kevin A. Clayton, Alicia A. Van Enoo, Tsuneya Ikezu · 2017 · Frontiers in Neuroscience
  90. Current progress in beta-amyloid immunotherapy
    Dale Schenk, Michael Hagen, Peter A. Seubert · 2004 · Current Opinion in Immunology
  91. Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
    Pitt, Jason, Roth, William, Lacor, Pascale, Smith, Amos B., Blankenship, Matthew, Velasco, Pauline, De Felice, Fernanda, Breslin, Paul, Klein, William L. · 2009 · Toxicology and Applied Pharmacology
  92. The endocytic pathway in microglia during health, aging and Alzheimer’s disease
    Solé-Domènech, Santiago, Cruz, Dana L., Capetillo-Zarate, Estibaliz, Maxfield, Frederick R. · 2016 · Ageing Research Reviews
  93. Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
    Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seubert, P. et al. · 2008 · Journal of Neuroscience
  94. Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products
    Manika Awasthi, Swati Singh, Veda Prakash Pandey, Upendra Nath Dwivedi · 2016 · Journal of the Neurological Sciences
  95. Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response
    Marcel Maier, Timothy J. Seabrook, Noel D. Lazo, Liying Jiang, Pritam Das, Christopher Janus, Cynthia Ann Lemere · 2006 · Journal of Neuroscience
  96. Animal models of Alzheimer disease: historical pitfalls and a path forward
    Cavanaugh, Sarah E. · 2014 · ALTEX
  97. Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation
    Rashmi Vasundhara Gamage, Ingrid Marguerite Wagnon, Ilaria Rossetti, Ryan Childs, Garry Niedermayer, Rose Chesworth, Erika Gyengési · 2020 · Frontiers in Cellular Neuroscience
  98. Purinergic systems in microglia
    Kazuhide Inoue · 2008 · Cellular and Molecular Life Sciences
  99. Intramembrane proteolysis by presenilins
    Steiner, Harald, Haass, Christian · 2000 · Nature Reviews Molecular Cell Biology
  100. Targeted delivery of protein and gene medicines through the blood–brain barrier
    William M. Pardridge · 2014 · Clinical Pharmacology & Therapeutics